Literature DB >> 7797110

Recent advances in the endoscopic management of variceal bleeding.

S G Williams1, D Westaby.   

Abstract

For the first time the endoscopist has more than one option for the management of gastro-oesophageal varices. It is now feasible to select the appropriate therapy on the basis of the clinical setting. Acute injection sclerotherapy remains a quick and simple technique for the control of active bleeding from oesophageal varices, and could be followed two or three days later by banding ligation. Earlier obliteration of varices with this technique may offer the prospect of only two or three sessions of therapy. The availability of the tissue adhesives and thrombin as injectates for fundal gastric varices provide the option of an initial attempt at endoscopic therapy in this high risk group.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797110      PMCID: PMC1382662          DOI: 10.1136/gut.36.5.647

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  A new endoscopic elastic band ligating device.

Authors:  G Van Stiegmann; T Cambre; J H Sun
Journal:  Gastrointest Endosc       Date:  1986-06       Impact factor: 9.427

2.  Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial.

Authors:  K J Paquet; H Feussner
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

3.  Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.

Authors:  A E Gimson; J K Ramage; M Z Panos; K Hayllar; P M Harrison; R Williams; D Westaby
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

4.  [Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients].

Authors:  A Sée; C Florent; P Lamy; V G Lévy; M Bouvry
Journal:  Gastroenterol Clin Biol       Date:  1986 Aug-Sep

Review 5.  Complications of endoscopic injection sclerotherapy: a review.

Authors:  B M Schuman; J W Beckman; F J Tedesco; J W Griffin; R T Assad
Journal:  Am J Gastroenterol       Date:  1987-09       Impact factor: 10.864

6.  N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy.

Authors:  N Soehendra; H Grimm; V C Nam; B Berger
Journal:  Endoscopy       Date:  1987-11       Impact factor: 10.093

7.  A comparison of immediate versus delayed endoscopic injection sclerosis of bleeding esophageal varices.

Authors:  T Prindiville; W Trudeau
Journal:  Gastrointest Endosc       Date:  1986-12       Impact factor: 9.427

8.  Comparison of 1% sodium tetradecyl sulfate to a thrombogenic sclerosant cocktail for endoscopic sclerotherapy.

Authors:  S D Lyons; C Sugawa; E R Geller; D M Vandenberg
Journal:  Am Surg       Date:  1988-02       Impact factor: 0.688

9.  Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices.

Authors:  M S Barsoum; F I Bolous; A A El-Rooby; M A Rizk-Allah; A S Ibrahim
Journal:  Br J Surg       Date:  1982-02       Impact factor: 6.939

10.  Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone.

Authors:  E Christensen; L Fauerholdt; P Schlichting; E Juhl; H Poulsen; N Tygstrup
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

View more
  3 in total

1.  Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.

Authors:  Jake E J Krige; Urda K Kotze; Philippus C Bornman; John M Shaw; Michael Klipin
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 2.  A practical guide to the management of oesophageal varices.

Authors:  G McCormack; P A McCormick
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

3.  Transparent cap-assisted endoscopic injection sclerotherapy for the treatment of patients with esophageal varices.

Authors:  Jing Wang; Xiaohua Zhang; Shulei Zhao
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.